Status:
UNKNOWN
Prognostic Value of Central and BracHial Ambulatory Blood Pressure Monitoring in ERSD Patients Treated With HeMOdialysis
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
Brief Summary
This is a prospective cohort study which aims to explore the significance of brachial and central ambulatory blood pressure monitoring in predicting cardiovascular risk in patients with end stage rena...
Detailed Description
The protocol of this study was approved by the local ethical review board. The including criteria: 1) ESRD treated with hemodialysis for more than 3 months prior to study enrollment; 2) agree to parti...
Eligibility Criteria
Inclusion
- patients with end-stage renal disease treated with hemodialysis for more than 3 months prior to study enrollment;
- agree to participate the study and sign informed written consent;
- available for long-term follow-up.
Exclusion
- chronic atrial fibrillation or other cardiac arrhythmia;
- nonfunctional arteriovenous fistula in the contralateral brachial area of the one used for dialysis;
- myocardial infarction, angina pectoris and ischemic stroke during the previous month;
- congestive heart failure class IV based on the New York Heart Association classification;
- malignancy or any other condition with poor prognosis;
- antihypertensive treatment during 1 month prior to enrollment.
Key Trial Info
Start Date :
October 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 9 2020
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT03306160
Start Date
October 10 2017
End Date
October 9 2020
Last Update
October 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tenth People's Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China, 200072